Global Point-of-care Testing (POCT) for Chronic Disease Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Page: 115
Published Date: 11 Jan 2024
Category: Medical Devices & Consumables
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Point-of-care Testing (POCT) for Chronic Disease market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
The Global Info Research report includes an overview of the development of the Point-of-care Testing (POCT) for Chronic Disease industry chain, the market status of Hospital (Based on Immunochromatography, Based on Chemiluminescence Technology), lndependent Testing Organization (Based on Immunochromatography, Based on Chemiluminescence Technology), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Point-of-care Testing (POCT) for Chronic Disease.
Regionally, the report analyzes the Point-of-care Testing (POCT) for Chronic Disease markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Point-of-care Testing (POCT) for Chronic Disease market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Point-of-care Testing (POCT) for Chronic Disease market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Point-of-care Testing (POCT) for Chronic Disease industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Based on Immunochromatography, Based on Chemiluminescence Technology).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Point-of-care Testing (POCT) for Chronic Disease market.
Regional Analysis: The report involves examining the Point-of-care Testing (POCT) for Chronic Disease market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Point-of-care Testing (POCT) for Chronic Disease market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Point-of-care Testing (POCT) for Chronic Disease:
Company Analysis: Report covers individual Point-of-care Testing (POCT) for Chronic Disease manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Point-of-care Testing (POCT) for Chronic Disease This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, lndependent Testing Organization).
Technology Analysis: Report covers specific technologies relevant to Point-of-care Testing (POCT) for Chronic Disease. It assesses the current state, advancements, and potential future developments in Point-of-care Testing (POCT) for Chronic Disease areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Point-of-care Testing (POCT) for Chronic Disease market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Point-of-care Testing (POCT) for Chronic Disease market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Based on Immunochromatography
Based on Chemiluminescence Technology
Based on Biosensor
Others
Market segment by Application
Hospital
lndependent Testing Organization
Major players covered
Abbott
BioMerieux
Siemens Healthineers
Roche
Danaher
Sinocare Inc
Assure Tech (Hangzhou) Co.,Ltd.
Bio-Rad Laboratories
Guangzhou Wondfo Biotech Co.,Ltd.
Wuhan Easy Diagnosis Biomedicine Co.,ltd.
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Point-of-care Testing (POCT) for Chronic Disease product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Point-of-care Testing (POCT) for Chronic Disease, with price, sales, revenue and global market share of Point-of-care Testing (POCT) for Chronic Disease from 2019 to 2024.
Chapter 3, the Point-of-care Testing (POCT) for Chronic Disease competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Point-of-care Testing (POCT) for Chronic Disease breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Point-of-care Testing (POCT) for Chronic Disease market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Point-of-care Testing (POCT) for Chronic Disease.
Chapter 14 and 15, to describe Point-of-care Testing (POCT) for Chronic Disease sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Point-of-care Testing (POCT) for Chronic Disease
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Based on Immunochromatography
1.3.3 Based on Chemiluminescence Technology
1.3.4 Based on Biosensor
1.3.5 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 lndependent Testing Organization
1.5 Global Point-of-care Testing (POCT) for Chronic Disease Market Size & Forecast
1.5.1 Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Point-of-care Testing (POCT) for Chronic Disease Sales Quantity (2019-2030)
1.5.3 Global Point-of-care Testing (POCT) for Chronic Disease Average Price (2019-2030)
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott Point-of-care Testing (POCT) for Chronic Disease Product and Services
2.1.4 Abbott Point-of-care Testing (POCT) for Chronic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Abbott Recent Developments/Updates
2.2 BioMerieux
2.2.1 BioMerieux Details
2.2.2 BioMerieux Major Business
2.2.3 BioMerieux Point-of-care Testing (POCT) for Chronic Disease Product and Services
2.2.4 BioMerieux Point-of-care Testing (POCT) for Chronic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 BioMerieux Recent Developments/Updates
2.3 Siemens Healthineers
2.3.1 Siemens Healthineers Details
2.3.2 Siemens Healthineers Major Business
2.3.3 Siemens Healthineers Point-of-care Testing (POCT) for Chronic Disease Product and Services
2.3.4 Siemens Healthineers Point-of-care Testing (POCT) for Chronic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Siemens Healthineers Recent Developments/Updates
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business
2.4.3 Roche Point-of-care Testing (POCT) for Chronic Disease Product and Services
2.4.4 Roche Point-of-care Testing (POCT) for Chronic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Roche Recent Developments/Updates
2.5 Danaher
2.5.1 Danaher Details
2.5.2 Danaher Major Business
2.5.3 Danaher Point-of-care Testing (POCT) for Chronic Disease Product and Services
2.5.4 Danaher Point-of-care Testing (POCT) for Chronic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Danaher Recent Developments/Updates
2.6 Sinocare Inc
2.6.1 Sinocare Inc Details
2.6.2 Sinocare Inc Major Business
2.6.3 Sinocare Inc Point-of-care Testing (POCT) for Chronic Disease Product and Services
2.6.4 Sinocare Inc Point-of-care Testing (POCT) for Chronic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Sinocare Inc Recent Developments/Updates
2.7 Assure Tech (Hangzhou) Co.,Ltd.
2.7.1 Assure Tech (Hangzhou) Co.,Ltd. Details
2.7.2 Assure Tech (Hangzhou) Co.,Ltd. Major Business
2.7.3 Assure Tech (Hangzhou) Co.,Ltd. Point-of-care Testing (POCT) for Chronic Disease Product and Services
2.7.4 Assure Tech (Hangzhou) Co.,Ltd. Point-of-care Testing (POCT) for Chronic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Assure Tech (Hangzhou) Co.,Ltd. Recent Developments/Updates
2.8 Bio-Rad Laboratories
2.8.1 Bio-Rad Laboratories Details
2.8.2 Bio-Rad Laboratories Major Business
2.8.3 Bio-Rad Laboratories Point-of-care Testing (POCT) for Chronic Disease Product and Services
2.8.4 Bio-Rad Laboratories Point-of-care Testing (POCT) for Chronic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Bio-Rad Laboratories Recent Developments/Updates
2.9 Guangzhou Wondfo Biotech Co.,Ltd.
2.9.1 Guangzhou Wondfo Biotech Co.,Ltd. Details
2.9.2 Guangzhou Wondfo Biotech Co.,Ltd. Major Business
2.9.3 Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Chronic Disease Product and Services
2.9.4 Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Chronic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Guangzhou Wondfo Biotech Co.,Ltd. Recent Developments/Updates
2.10 Wuhan Easy Diagnosis Biomedicine Co.,ltd.
2.10.1 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Details
2.10.2 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Major Business
2.10.3 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Point-of-care Testing (POCT) for Chronic Disease Product and Services
2.10.4 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Point-of-care Testing (POCT) for Chronic Disease Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Recent Developments/Updates
3.1 Global Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Manufacturer (2019-2024)
3.2 Global Point-of-care Testing (POCT) for Chronic Disease Revenue by Manufacturer (2019-2024)
3.3 Global Point-of-care Testing (POCT) for Chronic Disease Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Point-of-care Testing (POCT) for Chronic Disease by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Point-of-care Testing (POCT) for Chronic Disease Manufacturer Market Share in 2023
3.4.2 Top 6 Point-of-care Testing (POCT) for Chronic Disease Manufacturer Market Share in 2023
3.5 Point-of-care Testing (POCT) for Chronic Disease Market: Overall Company Footprint Analysis
3.5.1 Point-of-care Testing (POCT) for Chronic Disease Market: Region Footprint
3.5.2 Point-of-care Testing (POCT) for Chronic Disease Market: Company Product Type Footprint
3.5.3 Point-of-care Testing (POCT) for Chronic Disease Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Point-of-care Testing (POCT) for Chronic Disease Market Size by Region
4.1.1 Global Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Region (2019-2030)
4.1.2 Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Region (2019-2030)
4.1.3 Global Point-of-care Testing (POCT) for Chronic Disease Average Price by Region (2019-2030)
4.2 North America Point-of-care Testing (POCT) for Chronic Disease Consumption Value (2019-2030)
4.3 Europe Point-of-care Testing (POCT) for Chronic Disease Consumption Value (2019-2030)
4.4 Asia-Pacific Point-of-care Testing (POCT) for Chronic Disease Consumption Value (2019-2030)
4.5 South America Point-of-care Testing (POCT) for Chronic Disease Consumption Value (2019-2030)
4.6 Middle East and Africa Point-of-care Testing (POCT) for Chronic Disease Consumption Value (2019-2030)
5.1 Global Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Type (2019-2030)
5.2 Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Type (2019-2030)
5.3 Global Point-of-care Testing (POCT) for Chronic Disease Average Price by Type (2019-2030)
6.1 Global Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Application (2019-2030)
6.2 Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Application (2019-2030)
6.3 Global Point-of-care Testing (POCT) for Chronic Disease Average Price by Application (2019-2030)
7.1 North America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Type (2019-2030)
7.2 North America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Application (2019-2030)
7.3 North America Point-of-care Testing (POCT) for Chronic Disease Market Size by Country
7.3.1 North America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Country (2019-2030)
7.3.2 North America Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8.1 Europe Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Type (2019-2030)
8.2 Europe Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Application (2019-2030)
8.3 Europe Point-of-care Testing (POCT) for Chronic Disease Market Size by Country
8.3.1 Europe Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Country (2019-2030)
8.3.2 Europe Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9.1 Asia-Pacific Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Point-of-care Testing (POCT) for Chronic Disease Market Size by Region
9.3.1 Asia-Pacific Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10.1 South America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Type (2019-2030)
10.2 South America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Application (2019-2030)
10.3 South America Point-of-care Testing (POCT) for Chronic Disease Market Size by Country
10.3.1 South America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Country (2019-2030)
10.3.2 South America Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11.1 Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Market Size by Country
11.3.1 Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12.1 Point-of-care Testing (POCT) for Chronic Disease Market Drivers
12.2 Point-of-care Testing (POCT) for Chronic Disease Market Restraints
12.3 Point-of-care Testing (POCT) for Chronic Disease Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13.1 Raw Material of Point-of-care Testing (POCT) for Chronic Disease and Key Manufacturers
13.2 Manufacturing Costs Percentage of Point-of-care Testing (POCT) for Chronic Disease
13.3 Point-of-care Testing (POCT) for Chronic Disease Production Process
13.4 Point-of-care Testing (POCT) for Chronic Disease Industrial Chain
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Point-of-care Testing (POCT) for Chronic Disease Typical Distributors
14.3 Point-of-care Testing (POCT) for Chronic Disease Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Abbott Basic Information, Manufacturing Base and Competitors
Table 4. Abbott Major Business
Table 5. Abbott Point-of-care Testing (POCT) for Chronic Disease Product and Services
Table 6. Abbott Point-of-care Testing (POCT) for Chronic Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Abbott Recent Developments/Updates
Table 8. BioMerieux Basic Information, Manufacturing Base and Competitors
Table 9. BioMerieux Major Business
Table 10. BioMerieux Point-of-care Testing (POCT) for Chronic Disease Product and Services
Table 11. BioMerieux Point-of-care Testing (POCT) for Chronic Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. BioMerieux Recent Developments/Updates
Table 13. Siemens Healthineers Basic Information, Manufacturing Base and Competitors
Table 14. Siemens Healthineers Major Business
Table 15. Siemens Healthineers Point-of-care Testing (POCT) for Chronic Disease Product and Services
Table 16. Siemens Healthineers Point-of-care Testing (POCT) for Chronic Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Siemens Healthineers Recent Developments/Updates
Table 18. Roche Basic Information, Manufacturing Base and Competitors
Table 19. Roche Major Business
Table 20. Roche Point-of-care Testing (POCT) for Chronic Disease Product and Services
Table 21. Roche Point-of-care Testing (POCT) for Chronic Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Roche Recent Developments/Updates
Table 23. Danaher Basic Information, Manufacturing Base and Competitors
Table 24. Danaher Major Business
Table 25. Danaher Point-of-care Testing (POCT) for Chronic Disease Product and Services
Table 26. Danaher Point-of-care Testing (POCT) for Chronic Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Danaher Recent Developments/Updates
Table 28. Sinocare Inc Basic Information, Manufacturing Base and Competitors
Table 29. Sinocare Inc Major Business
Table 30. Sinocare Inc Point-of-care Testing (POCT) for Chronic Disease Product and Services
Table 31. Sinocare Inc Point-of-care Testing (POCT) for Chronic Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Sinocare Inc Recent Developments/Updates
Table 33. Assure Tech (Hangzhou) Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 34. Assure Tech (Hangzhou) Co.,Ltd. Major Business
Table 35. Assure Tech (Hangzhou) Co.,Ltd. Point-of-care Testing (POCT) for Chronic Disease Product and Services
Table 36. Assure Tech (Hangzhou) Co.,Ltd. Point-of-care Testing (POCT) for Chronic Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Assure Tech (Hangzhou) Co.,Ltd. Recent Developments/Updates
Table 38. Bio-Rad Laboratories Basic Information, Manufacturing Base and Competitors
Table 39. Bio-Rad Laboratories Major Business
Table 40. Bio-Rad Laboratories Point-of-care Testing (POCT) for Chronic Disease Product and Services
Table 41. Bio-Rad Laboratories Point-of-care Testing (POCT) for Chronic Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Bio-Rad Laboratories Recent Developments/Updates
Table 43. Guangzhou Wondfo Biotech Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 44. Guangzhou Wondfo Biotech Co.,Ltd. Major Business
Table 45. Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Chronic Disease Product and Services
Table 46. Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Chronic Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Guangzhou Wondfo Biotech Co.,Ltd. Recent Developments/Updates
Table 48. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Basic Information, Manufacturing Base and Competitors
Table 49. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Major Business
Table 50. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Point-of-care Testing (POCT) for Chronic Disease Product and Services
Table 51. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Point-of-care Testing (POCT) for Chronic Disease Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Recent Developments/Updates
Table 53. Global Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 54. Global Point-of-care Testing (POCT) for Chronic Disease Revenue by Manufacturer (2019-2024) & (USD Million)
Table 55. Global Point-of-care Testing (POCT) for Chronic Disease Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 56. Market Position of Manufacturers in Point-of-care Testing (POCT) for Chronic Disease, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 57. Head Office and Point-of-care Testing (POCT) for Chronic Disease Production Site of Key Manufacturer
Table 58. Point-of-care Testing (POCT) for Chronic Disease Market: Company Product Type Footprint
Table 59. Point-of-care Testing (POCT) for Chronic Disease Market: Company Product Application Footprint
Table 60. Point-of-care Testing (POCT) for Chronic Disease New Market Entrants and Barriers to Market Entry
Table 61. Point-of-care Testing (POCT) for Chronic Disease Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Region (2019-2024) & (K Units)
Table 63. Global Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Region (2025-2030) & (K Units)
Table 64. Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Region (2019-2024) & (USD Million)
Table 65. Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Region (2025-2030) & (USD Million)
Table 66. Global Point-of-care Testing (POCT) for Chronic Disease Average Price by Region (2019-2024) & (US$/Unit)
Table 67. Global Point-of-care Testing (POCT) for Chronic Disease Average Price by Region (2025-2030) & (US$/Unit)
Table 68. Global Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Type (2019-2024) & (K Units)
Table 69. Global Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Type (2025-2030) & (K Units)
Table 70. Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Type (2019-2024) & (USD Million)
Table 71. Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Type (2025-2030) & (USD Million)
Table 72. Global Point-of-care Testing (POCT) for Chronic Disease Average Price by Type (2019-2024) & (US$/Unit)
Table 73. Global Point-of-care Testing (POCT) for Chronic Disease Average Price by Type (2025-2030) & (US$/Unit)
Table 74. Global Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Application (2019-2024) & (K Units)
Table 75. Global Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Application (2025-2030) & (K Units)
Table 76. Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Application (2019-2024) & (USD Million)
Table 77. Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Application (2025-2030) & (USD Million)
Table 78. Global Point-of-care Testing (POCT) for Chronic Disease Average Price by Application (2019-2024) & (US$/Unit)
Table 79. Global Point-of-care Testing (POCT) for Chronic Disease Average Price by Application (2025-2030) & (US$/Unit)
Table 80. North America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Type (2019-2024) & (K Units)
Table 81. North America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Type (2025-2030) & (K Units)
Table 82. North America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Application (2019-2024) & (K Units)
Table 83. North America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Application (2025-2030) & (K Units)
Table 84. North America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Country (2019-2024) & (K Units)
Table 85. North America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Country (2025-2030) & (K Units)
Table 86. North America Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Country (2019-2024) & (USD Million)
Table 87. North America Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Country (2025-2030) & (USD Million)
Table 88. Europe Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Type (2019-2024) & (K Units)
Table 89. Europe Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Type (2025-2030) & (K Units)
Table 90. Europe Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Application (2019-2024) & (K Units)
Table 91. Europe Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Application (2025-2030) & (K Units)
Table 92. Europe Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Country (2019-2024) & (K Units)
Table 93. Europe Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Country (2025-2030) & (K Units)
Table 94. Europe Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Country (2019-2024) & (USD Million)
Table 95. Europe Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Country (2025-2030) & (USD Million)
Table 96. Asia-Pacific Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Type (2019-2024) & (K Units)
Table 97. Asia-Pacific Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Type (2025-2030) & (K Units)
Table 98. Asia-Pacific Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Application (2019-2024) & (K Units)
Table 99. Asia-Pacific Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Application (2025-2030) & (K Units)
Table 100. Asia-Pacific Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Region (2019-2024) & (K Units)
Table 101. Asia-Pacific Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Region (2025-2030) & (K Units)
Table 102. Asia-Pacific Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Region (2019-2024) & (USD Million)
Table 103. Asia-Pacific Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Region (2025-2030) & (USD Million)
Table 104. South America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Type (2019-2024) & (K Units)
Table 105. South America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Type (2025-2030) & (K Units)
Table 106. South America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Application (2019-2024) & (K Units)
Table 107. South America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Application (2025-2030) & (K Units)
Table 108. South America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Country (2019-2024) & (K Units)
Table 109. South America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Country (2025-2030) & (K Units)
Table 110. South America Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Country (2019-2024) & (USD Million)
Table 111. South America Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Country (2025-2030) & (USD Million)
Table 112. Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Type (2019-2024) & (K Units)
Table 113. Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Type (2025-2030) & (K Units)
Table 114. Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Application (2019-2024) & (K Units)
Table 115. Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Application (2025-2030) & (K Units)
Table 116. Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Region (2019-2024) & (K Units)
Table 117. Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Sales Quantity by Region (2025-2030) & (K Units)
Table 118. Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Region (2019-2024) & (USD Million)
Table 119. Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Region (2025-2030) & (USD Million)
Table 120. Point-of-care Testing (POCT) for Chronic Disease Raw Material
Table 121. Key Manufacturers of Point-of-care Testing (POCT) for Chronic Disease Raw Materials
Table 122. Point-of-care Testing (POCT) for Chronic Disease Typical Distributors
Table 123. Point-of-care Testing (POCT) for Chronic Disease Typical Customers
List of Figures
Figure 1. Point-of-care Testing (POCT) for Chronic Disease Picture
Figure 2. Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value Market Share by Type in 2023
Figure 4. Based on Immunochromatography Examples
Figure 5. Based on Chemiluminescence Technology Examples
Figure 6. Based on Biosensor Examples
Figure 7. Others Examples
Figure 8. Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 9. Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value Market Share by Application in 2023
Figure 10. Hospital Examples
Figure 11. lndependent Testing Organization Examples
Figure 12. Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Point-of-care Testing (POCT) for Chronic Disease Sales Quantity (2019-2030) & (K Units)
Figure 15. Global Point-of-care Testing (POCT) for Chronic Disease Average Price (2019-2030) & (US$/Unit)
Figure 16. Global Point-of-care Testing (POCT) for Chronic Disease Sales Quantity Market Share by Manufacturer in 2023
Figure 17. Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value Market Share by Manufacturer in 2023
Figure 18. Producer Shipments of Point-of-care Testing (POCT) for Chronic Disease by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 19. Top 3 Point-of-care Testing (POCT) for Chronic Disease Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Top 6 Point-of-care Testing (POCT) for Chronic Disease Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Global Point-of-care Testing (POCT) for Chronic Disease Sales Quantity Market Share by Region (2019-2030)
Figure 22. Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value Market Share by Region (2019-2030)
Figure 23. North America Point-of-care Testing (POCT) for Chronic Disease Consumption Value (2019-2030) & (USD Million)
Figure 24. Europe Point-of-care Testing (POCT) for Chronic Disease Consumption Value (2019-2030) & (USD Million)
Figure 25. Asia-Pacific Point-of-care Testing (POCT) for Chronic Disease Consumption Value (2019-2030) & (USD Million)
Figure 26. South America Point-of-care Testing (POCT) for Chronic Disease Consumption Value (2019-2030) & (USD Million)
Figure 27. Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Consumption Value (2019-2030) & (USD Million)
Figure 28. Global Point-of-care Testing (POCT) for Chronic Disease Sales Quantity Market Share by Type (2019-2030)
Figure 29. Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value Market Share by Type (2019-2030)
Figure 30. Global Point-of-care Testing (POCT) for Chronic Disease Average Price by Type (2019-2030) & (US$/Unit)
Figure 31. Global Point-of-care Testing (POCT) for Chronic Disease Sales Quantity Market Share by Application (2019-2030)
Figure 32. Global Point-of-care Testing (POCT) for Chronic Disease Consumption Value Market Share by Application (2019-2030)
Figure 33. Global Point-of-care Testing (POCT) for Chronic Disease Average Price by Application (2019-2030) & (US$/Unit)
Figure 34. North America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity Market Share by Type (2019-2030)
Figure 35. North America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity Market Share by Application (2019-2030)
Figure 36. North America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity Market Share by Country (2019-2030)
Figure 37. North America Point-of-care Testing (POCT) for Chronic Disease Consumption Value Market Share by Country (2019-2030)
Figure 38. United States Point-of-care Testing (POCT) for Chronic Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Canada Point-of-care Testing (POCT) for Chronic Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Mexico Point-of-care Testing (POCT) for Chronic Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Europe Point-of-care Testing (POCT) for Chronic Disease Sales Quantity Market Share by Type (2019-2030)
Figure 42. Europe Point-of-care Testing (POCT) for Chronic Disease Sales Quantity Market Share by Application (2019-2030)
Figure 43. Europe Point-of-care Testing (POCT) for Chronic Disease Sales Quantity Market Share by Country (2019-2030)
Figure 44. Europe Point-of-care Testing (POCT) for Chronic Disease Consumption Value Market Share by Country (2019-2030)
Figure 45. Germany Point-of-care Testing (POCT) for Chronic Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. France Point-of-care Testing (POCT) for Chronic Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. United Kingdom Point-of-care Testing (POCT) for Chronic Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Russia Point-of-care Testing (POCT) for Chronic Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Italy Point-of-care Testing (POCT) for Chronic Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Asia-Pacific Point-of-care Testing (POCT) for Chronic Disease Sales Quantity Market Share by Type (2019-2030)
Figure 51. Asia-Pacific Point-of-care Testing (POCT) for Chronic Disease Sales Quantity Market Share by Application (2019-2030)
Figure 52. Asia-Pacific Point-of-care Testing (POCT) for Chronic Disease Sales Quantity Market Share by Region (2019-2030)
Figure 53. Asia-Pacific Point-of-care Testing (POCT) for Chronic Disease Consumption Value Market Share by Region (2019-2030)
Figure 54. China Point-of-care Testing (POCT) for Chronic Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Japan Point-of-care Testing (POCT) for Chronic Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Korea Point-of-care Testing (POCT) for Chronic Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. India Point-of-care Testing (POCT) for Chronic Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Southeast Asia Point-of-care Testing (POCT) for Chronic Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Australia Point-of-care Testing (POCT) for Chronic Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. South America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity Market Share by Type (2019-2030)
Figure 61. South America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity Market Share by Application (2019-2030)
Figure 62. South America Point-of-care Testing (POCT) for Chronic Disease Sales Quantity Market Share by Country (2019-2030)
Figure 63. South America Point-of-care Testing (POCT) for Chronic Disease Consumption Value Market Share by Country (2019-2030)
Figure 64. Brazil Point-of-care Testing (POCT) for Chronic Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Argentina Point-of-care Testing (POCT) for Chronic Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Sales Quantity Market Share by Type (2019-2030)
Figure 67. Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Sales Quantity Market Share by Application (2019-2030)
Figure 68. Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Sales Quantity Market Share by Region (2019-2030)
Figure 69. Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Consumption Value Market Share by Region (2019-2030)
Figure 70. Turkey Point-of-care Testing (POCT) for Chronic Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Egypt Point-of-care Testing (POCT) for Chronic Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Saudi Arabia Point-of-care Testing (POCT) for Chronic Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. South Africa Point-of-care Testing (POCT) for Chronic Disease Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Point-of-care Testing (POCT) for Chronic Disease Market Drivers
Figure 75. Point-of-care Testing (POCT) for Chronic Disease Market Restraints
Figure 76. Point-of-care Testing (POCT) for Chronic Disease Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Point-of-care Testing (POCT) for Chronic Disease in 2023
Figure 79. Manufacturing Process Analysis of Point-of-care Testing (POCT) for Chronic Disease
Figure 80. Point-of-care Testing (POCT) for Chronic Disease Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Abbott BioMerieux Siemens Healthineers Roche Danaher Sinocare Inc Assure Tech (Hangzhou) Co.,Ltd. Bio-Rad Laboratories Guangzhou Wondfo Biotech Co.,Ltd. Wuhan Easy Diagnosis Biomedicine Co.,ltd.
Related Reports
24 Feb 2023
Medical Devices & Consumables
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
